Owner Merck & Co., Inc.

Inventors Cox, Christopher D.; Mariano, Brenda J.; Breslin, Michael J.; Hartman, George D.; Coleman, Paul J.

Agent Spruson & Ferguson

Pub. Number AU-B-2003287057

PCT Number PCT/US2003/0324

PCT Pub. Number WO2004/037171

Priority 60/419,570 18.10.02 US; 60/479,712 19.06.03 US

Filing date 14 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 21 August 2008

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07D 207/20 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom